We are delighted to share that a new article on Real-World Data (RWD) and Real-World Evidence (RWE) is now available in the EUPATI Toolbox here.
This article explores Real-World Data (RWD) and Real-World Evidence (RWE), highlighting their sources, types, and key considerations for addressing potential bias. It examines the advantages of RWE studies compared to Randomized Clinical Trials (RCTs) and discusses best practices and regulatory initiatives in Health Technology and Regulatory Affairs.
Additionally, this article outlines relevant guidances on RWD use and emphasizes the critical role patients play in shaping both RWD and RWE.
Access this new article here.
The EUPATI Toolbox is an online library on the A-Z of medicines research and development (R&D) and patient engagement. The purpose of the Toolbox is to provide access to well-structured, comprehensive, scientifically reliable, and user-friendly educational materials for patients on a variety of topics in these areas. The information is not medicine- or disease-specific, but is applicable to the majority of diseases and/or medicines. This resource is free and contains information in 14 languages.
The Toolbox is continuously expanded and improved with new materials, reflecting the latest scientific discoveries and most relevant news and events related to medicines research and development (R&D).
Date posted: March 3, 2025
Categories: Uncategorized
